Hugh Cole - Insider Trading & Ownership

Entity
Individual
Location
C/O Ariad Pharmaceuticals, Inc, 26 Landsdowne Street, Cambridge, MA
Summary
The estimated net worth of Hugh Cole is at least $204K dollars as of June 6, 2024. Hugh Cole is the Chief Operating Officer of Jounce Therapeutics, Inc. and owns shares of Jounce Therapeutics, Inc. stock worth about $204K.
All Insider Reports
All Insider Reports

Ownership of Hugh Cole

Insider Transactions Reported by Hugh Cole:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.